Physiotherapy in your pocket

Using apps to support functional rehabilitation

2023-05-31

(Press-News.org) Apps have become ubiquitous in many parts of life, including for health. For people with an RMD, personalized video exercises (PEV) may be useful to support rehabilitation and physical exercise.

In an abstract shared at the 2023 EULAR annual congress, Davergne and colleagues explore the effectiveness of PEV provided through Apps in supporting rehabilitation for people with disability. The impact was measured in terms of a range of outcomes, including the effect on functional capacity, confidence in exercise performance, use of care, health-related quality of life, adherence, and adverse events.

Data were collected in a systematic review of randomized controlled trials which evaluated the effect of Apps providing PEV to support physical rehabilitation for any RMD. The primary outcome was functional capacity at the end of the intervention.

In total, 7 articles were included, representing data from 906 participants, 93% of whom were adults. The Apps used in these studies were mostly commercial, and 80% of the videos included content from a physiotherapist. The duration of App use ranged from 3 to 48 weeks.

Low-quality evidence suggested the use of Apps providing PEV led to a significant, but small-to-moderate improvement in physical function, confidence in exercise performance, quality of life, and adherence. However, use of Apps providing PEV did not influence rate of adverse events experienced by people taking part in the trials.

Whilst these results are interesting, the authors note that the level of evidence was low. More robust studies are needed to confirm these findings in people with RMD, and to work out which features of Apps and PEV have the greatest impact.

Source:

Davergne T, et al. The effectiveness of digital applications providing personalized exercise videos in individuals with rheumatic and musculoskeletal diseases: a systematic review with meta-analysis. Presented at EULAR 2023; Abstract OP0092-HPR.

About EULAR
EULAR is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with rheumatic and musculoskeletal diseases (RMDs). EULAR aims to reduce the impact of RMDs on individuals and society, as well as improve RMD treatments, prevention, and rehabilitation. To this end, EULAR fosters excellence in rheumatology education and research, promotes the translation of research advances into daily care, and advocates for the recognition of the needs of those living with RMDs by EU institutions.

Contact
EULAR Communications, communications@eular.org

Notes to Editors
EULAR Recommendations
EULAR School of Rheumatology
EULAR Press Releases

END

ELSE PRESS RELEASES FROM THIS DATE:

CV risk in psoriatic arthritis

2023-05-31

“This evidence suggests that inflammation in PsA is not limited to skin and joints, but also involves the cardiovascular system”, says Nienke Kleinrensink, lead author on the abstract shared in a session on Comorbidities in RMD at the 2023 EULAR congress in Milan, Italy. The new finding is based on work done at UMC Utrecht in the Netherlands. Part of the study was funded by Pfizer and Health Holland. The main objective was to investigate whether vascular inflammation is elevated in PsA patients. The team used positron emission tomography/computed tomography (PET/CT) in 75 people with PsA with active peripheral arthritis, ...

Cardiovascular considerations in RA

2023-05-31

The increased cardiovascular risks in RA include acute coronary syndromes (ACS). The extent to which DMARD-induced remission could reduce the risk of ACS in RA versus rates in the general population – and whether there are DMARD-specific beneficial effects on ACS risk – remain unknown. In a session titled, From hearts to lungs: comobidities in RA, Delcoigne and colleagues present new data on the risk of ACS in patients with RA who attained remission with methotrexate (MTX) or a tumor necrosis factor inhibitor (TNFi). The researchers defined and pooled cohorts of RA patients from registers in Norway and Sweden. This included 14,488 treatment courses ...

A closer look into axial spondyloarthritis

2023-05-31

There is a large diagnostic delay for people with axial spondyloarthritis (axSpA). In 2008, the SPACE cohort started to assess the prevalence of axSpA – and the reliability of an early diagnosis in people with chronic back pain (CBP). Everyone taking part was under the age of 45, and with recent-onset CBP (over 3 months, and up to 2 years) of unknown origin. Now, Marques and colleagues present two abstracts of the 2-year primary outcome of the study at the EULAR congress. The first abstract assesses the 2-year prevalence of an axSpA diagnosis among people with recent onset CBP who had been referred to a rheumatologist and investigates the sustainability of a baseline diagnosis ...

COVID and RA

2023-05-31

Studies on the long-term consequences of COVID-19 (long-COVID) in patients with inflammatory rheumatic diseases (iRD) are scarce. Where available data do exist, they tend to be heterogeneous and largely inconclusive. In addition, it is not known whether correctly classifying patients with iRD as long-COVID cases is complicated by increased background noise due to the occurrence of persistent symptoms that could be attributed to either long-COVID or iRD. A team in the Netherlands aimed to compare the risk of developing long-COVID after infection with the Omicron ...

FMF: Factors associated with delayed diagnosis

2023-05-31

EULAR – The European Alliance of Associations for Rheumatology – held its 2023 annual congress in Milan, Italy. One of the abstracts chosen for presentation in the scientific session on Rheumatic and Musculoskeletal diseases (RMDs) in children and young people, focused on the factors associated with diagnostic delay in FMF, using data from the Juvenile Inflammatory Rheumatism (JIR) cohort. Of 960 FMF patients enrolled, 80% received a diagnosis within 10 years of symptom onset; the remaining 20% had delayed diagnosis, and were significantly older with median age of 46.4 versus ...

Autoimmune diseases affect one in ten

2023-05-31

EULAR – the European Alliance of Associations for Rheumatology – works on a broad spectrum of autoimmune and auto-inflammatory diseases. A rise in the incidence of some of these has been described, raising the possibility that incidence might be impacted by environmental factors. But there is a lack of available data, and commonalities and differences between some individual diseases also remain poorly understood. Conrad and colleagues aimed to clarify the picture by investigating 19 of the most common autoimmune diseases. Their work – shared at the 2023 EULAR congress in Milan, Italy – assesses trends over time, by sex, age, socioeconomic status, season ...

Exploring the role of AI in early RA

2023-05-31

Early inflammatory arthritis is often undifferentiated, but it may develop into established RA or another arthropathy.1 Alternatively, it may resolve spontaneously, or remain undifferentiated for indefinite periods. Erosion is a key prognostic factor which can be detected with magnetic resonance imaging (MRI).2 In addition, MRI allows direct visualization and assessment of (teno-) synovitis and bone marrow edema.3 Predicting early RA from MRI images of the hands and feet can help people access timely treatment, which may possibly ...

Smoking cessation and changes in anxiety, depression in adults with and without psychiatric disorders

2023-05-31

About The Study: In this study of 4,260 adults with and without psychiatric disorders, smoking cessation, sustained for at least 15 weeks, was associated with improved mental health outcomes in observational analyses, but the instrumental variable analysis provided inconclusive evidence. Findings like these may reassure people who smoke and their clinicians that smoking cessation likely will not worsen and may improve mental health. Authors: Angela Difeng Wu, M.Sc., of the University of Oxford in Oxford, United Kingdom, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2023.16111) Editor’s ...

Landmark study finds that the shape of the brain influences the way it works

2023-05-31

For over a century, researchers have thought that the patterns of brain activity that define our experiences, hopes and dreams are determined by how different brain regions communicate with each other through a complex web of trillions of cellular connections. Now, a study led by from researchers at Monash University's Turner Institute for Brain and Mental Health has examined more than 10,000 different maps of human brain activity and found that the overall shape of a person’s brain exerts a far greater influence on how we think, feel and behave than its intricate neuronal connectivity. The study, published ...

New ‘designer’ titanium alloys made using 3D printing

2023-05-31

A team of researchers has created a new class of titanium alloys that are strong and not brittle under tension, by integrating alloy and 3D-printing process designs. The breakthrough, published in the top journal Nature, could help extend the applications of titanium alloys, improve sustainability and drive innovative alloy design. Their discovery holds promise for a new class of more sustainable high-performance titanium alloys for applications in aerospace, biomedical, chemical engineering, space and energy technologies. RMIT University and the University of Sydney led the innovation, in collaboration with Hong Kong Polytechnic University and the company Hexagon Manufacturing Intelligence ...

One of the largest studies on preterm birth finds a maternal biomarker test significantly reduces neonatal morbidities and improves neonatal outcomes

One of the largest studies of its kind finds early intervention with iron delivered intravenously during pregnancy is a safe and effective treatment for anemia

Physiotherapy in your pocket

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: